- The seasonal influenza activity in the United States remains low.
- Influenza A viruses, including H3N2 and H1N1pdm09, predominated during this period.
- The percentage of respiratory specimens testing positive for influenza in clinical laboratories is 0.21%, indicating low activity.
- Outpatient illness surveillance shows that 1.1% of healthcare visits were for influenza-like illness (ILI), below the national baseline of 2.6%.
- The geographic spread of influenza varied, with one jurisdiction experiencing low activity and the majority experiencing minimal activity.
- Hospitalization rates and P&I mortality rates will be updated weekly starting later in the season.
- There were no reported influenza-associated pediatric deaths during the current season.
- An annual flu vaccine is recommended for everyone 6 months and older.
- Antiviral drugs are available for the treatment of flu illness.
- Virologic surveillance data, including virus characterization, provide information on the genetic and antigenic properties of circulating influenza viruses.
- The CDC provides additional information on national and international influenza surveillance through various sources.